In all four pancreatic cancer cell lines tested, we found decreased expression of cell cycleproteins, including E2F1, Cyclin D1, Cyclin E, Cdk2, Cdk4 and Cdk6, and increased expression of p21 and p27. This evidence concerns the gene CDK2 and familial pancreatic carcinoma.